Prosecution Insights
Last updated: August 17, 2026

Examiner: AULAKH, CHARANJIT

Tech Center 1600 • Art Units: 1621 1625 1652

This examiner grants 81% of resolved cases

Performance Statistics

80.8%
Allow Rate
+20.8% vs TC avg
1,810
Total Applications
-15.2%
Interview Lift
751
Avg Prosecution Days
Based on 1769 resolved cases, 2023–2026

Rejection Statute Breakdown

3.4%
§101 Eligibility
20.5%
§102 Novelty
14.9%
§103 Obviousness
43.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18265337 Compound And Organic Light Emitting Device Comprising The Same Non-Final OA LG Chem, Ltd.
18279903 PROCESS FOR PREPARING A MELAMINE CONDENSATION PRODUCT Non-Final OA BASF SE
18717509 BCL-XL/BCL-2 DUAL DEGRADERS FOR TREATMENT OF CANCERS Non-Final OA University of Florida Research Foundation, Incorporated
18843651 METHODS OF TREATING CANCER WITH IAP ANTAGONIST COMPOUNDS AND COMBINATION THERAPIES Non-Final OA Board of Regents, The University of Texas System
18558931 ALKYLAMIDE SUBSTITUTED, ANNULATED IMIDAZOLES AND USE THEREOF AS INSECTICIDES Non-Final OA Bayer Aktiengesellschaft
18719945 AQUEOUS COSMETIC COMPOSITION COMPRISING VANILLIN OR ONE OF ITS DERIVATIVES, A SPECIFIC SEQUESTERING AGENT, AND POSSIBLY AT LEAST ONE ADDITIONAL ANTIMICROBIAL Non-Final OA L'OREAL
17919650 TARGETING THE PALMOTYLATION/DEPALMOTYLATION CYCLE TO TREAT INFLAMMATORY DISEASES Final Rejection CORNELL UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month